Metrochem Lacosamide Metrochem Lacosamide

X

Find Radio Compass News for Lacosamide

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
575
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

SERVICES

0

left grey arrow
right gray arrow
  • TABLET;ORAL - 100MG
  • TABLET;ORAL - 150MG
  • TABLET;ORAL - 200MG
  • TABLET;ORAL - 50MG

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218014

FDA
02 Apr 2024

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204839

FDA
27 Mar 2024

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217718

FDA
25 Mar 2024

https://www.prnewswire.com/news-releases/aucta-pharmaceuticals-inc-aucta-pharmaceuticals-launches-motpoly-xr-lacosamide-extended-release-capsules-c-v-the-first-and-only-once-daily-formulation-of-lacosamide-302070783.html

PR NEWSWIRE
26 Feb 2024

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217311

FDA
13 Feb 2024

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209224

FDA
24 Jan 2024

http://www.loncom.cn/show-1225.html

PRESS RELEASE
17 Jun 2023

https://www.ema.europa.eu/en/documents/overview/lacosamide-adroiq-epar-medicine-overview_en.pdf

EMA
05 Jun 2023

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204855

FDA
05 Jan 2023

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204994

FDA
05 Jan 2023

https://www.businesswire.com/news/home/20221215005073/en

BUSINESSWIRE
15 Dec 2022

https://www.ema.europa.eu/en/documents/overview/vimpat-epar-medicine-overview_en.pdf

EMA
08 Dec 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214567

FDA
23 Sep 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215628

FDA
19 Sep 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216335

FDA
14 Sep 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216151

FDA
26 Aug 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205011

FDA
12 Jul 2022

https://www.prnewswire.com/news-releases/breckenridge-pharmaceutical-inc-announces-launch-of-lacosamide-tablets-usp-generic-version-of-vimpat-manufactured-by-msn-laboratories-private-limited-301528326.html

PRNEWSWIRE
19 Apr 2022

http://www.loncom.cn/show-1218.html

PRESS RELEASE
18 Apr 2022

https://health.economictimes.indiatimes.com/news/pharma/fda-approves-indoco-remedies-lacosamide-injection/90732084

ET HEALTH
08 Apr 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214301

FDA
07 Apr 2022

https://tiefenbachergroup.com/2022/03/22/market-launch-epilepsy-medicine-lacosamide/

PRESS RELEASE
22 Mar 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204787

FDA
17 Mar 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204857

FDA
17 Mar 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204921

FDA
17 Mar 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204974

FDA
17 Mar 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205006

FDA
17 Mar 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205031

FDA
17 Mar 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205237

FDA
17 Mar 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208308

FDA
17 Mar 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208308

FDA
17 Mar 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214695

FDA
30 Mar 2021

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214672

FDA
17 Mar 2021

https://www.biopharmadive.com/news/ucb-gene-therapy-deal-lacerta-handl/588915/

Jonathan Gardner BIOPHARMADIVE
13 Nov 2020

https://www.biospace.com/article/releases/phase-3-data-on-vimpat-lacosamide-cv-in-primary-generalized-tonic-clonic-seizures-published-in-journal-of-neurology-neurosurgery-and-amp-psychiatry/

BIOSPACE
31 Aug 2020

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204921

FDA
14 May 2020

https://www.prnewswire.com/news-releases/ucb-presents-new-data-demonstrating-commitment-to-epilepsy-at-2019-american-epilepsy-society-meeting-300969719.html

PR NEWSWIRE
05 Dec 2019

https://www.gov.uk/drug-safety-update/letters-and-drug-alerts-sent-to-healthcare-professionals-in-july-2019

GOVUK
19 Aug 2019

http://www.pharmatimes.com/news/az_bags_two_extensions_in_latest_chmp_decisions_1292946

Anna Smith PHARMATIMES
01 Jul 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209301

FDA
11 May 2019

https://www.prnewswire.com/news-releases/lower-hospitalization-rates-in-epilepsy-patients-treated-with-adjunctive-fycompa-perampanel-ciii-300847474.html

PR NEWSWIRE
09 May 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204947

FDA
09 Apr 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206355

FDA
17 Aug 2018

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209224

FDA
14 Jul 2018

http://www.pharmatimes.com/news/ucbs_vimpat_gets_nhs_green_light_in_wales_1226338

Selina McKee PHARMA TIMES
08 Mar 2018

https://www.pharmacompass.com/pdf/news/accord-healthcares-lacosamide-accord-lacosamide-receives-approval-in-europe-1506577537.pdf

EMA
28 Sep 2017

http://www.pharmabiz.com/NewsDetails.aspx?aid=103932&sid=2

PHARMABIZ
28 Aug 2017

https://www.law360.com/lifesciences/articles/952305

Jimmy Hoover LAW360
09 Aug 2017

http://www.prnewswire.com/news-releases/argentum-persists-in-challenging-the-evergreening-patent-on-ucbs-vimpat-300428540.html

PR NEWSWIRE
23 Mar 2017

http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204999

FDA
01 Mar 2017
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY